IonQ director sells shares after RSU grant

IonQ, Inc. director Gabrielle B. Toledano reported a mix of equity compensation and share sales.

Rhea-AI Filing Summary

IonQ, Inc. director Gabrielle B. Toledano reported a mix of equity compensation and share sales. She received a grant of 4,526 shares of common stock as a restricted stock unit (RSU) award, which will vest in full on the earlier of the day before the next year’s annual meeting or June 17, 2027, subject to her continued board service.

She also sold 2,757 shares of common stock in an open-market transaction at a weighted average price of $55.01 per share, with individual sale prices ranging from $53.79 to $56.63. The sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2025. Following these transactions, she directly holds 11,154 shares of IonQ common stock.

Insider Trade Summary 10b5-1

Net Seller: 2,757 shares

Net Sell 2 txns

Insider TOLEDANO GABRIELLE B

Role Director

Sold 2,757 shs ($152K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,757	$55.01	$152K
Grant/Award	Common Stock	4,526	$0.00	$0.00

Holdings After Transaction: Common Stock — 11,154 shares (Direct)

Footnotes (3)

1. F1. Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the day before the date of the following year's Annual Meeting or (ii) June 17, 2027 subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.
2. F2. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2025.
3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.79 to $56.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 2,757 shares Weighted average sale price: $55.01 per share Sale price range: $53.79 to $56.63 +4 more

7 metrics

Shares sold 2,757 shares Open-market sale of IonQ common stock

Weighted average sale price $55.01 per share Open-market sale on June 18, 2026

Sale price range $53.79 to $56.63 Range of prices for sold shares

RSU grant size 4,526 shares Restricted stock unit award on June 17, 2026

Holdings after transactions 11,154 shares Direct IonQ common stock position post-transactions

RSU vesting date June 17, 2027 Latest possible full vesting date for RSU award

10b5-1 plan adoption date September 11, 2025 Date director adopted trading plan governing the sale

Key Terms

restricted stock unit ("RSU"), Rule 10b5-1 trading plan, weighted average price, Annual Meeting

4 terms

restricted stock unit ("RSU") financial

"Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of..."

Rule 10b5-1 trading plan regulatory

"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions..."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Annual Meeting other

"The RSUs will vest in full on the earlier of (i) the day before the date of the following year's Annual Meeting..."

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did IonQ (IONQ) director Gabrielle Toledano report?

Gabrielle Toledano reported receiving 4,526 restricted stock units and selling 2,757 IonQ common shares. The sale was an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan, and she now directly holds 11,154 shares of common stock.

How many IonQ (IONQ) shares did the director sell and at what price?

She sold 2,757 IonQ common shares at a weighted average price of $55.01 per share. The transactions occurred at prices ranging from $53.79 to $56.63, and were executed as part of an open-market sale under a Rule 10b5-1 trading plan.

What are the details of Gabrielle Toledano’s RSU grant at IonQ (IONQ)?

She received a restricted stock unit award covering 4,526 shares of IonQ common stock. These RSUs will vest in full on the earlier of the day before next year’s annual meeting or June 17, 2027, contingent on her continued service on the board of directors.

Was the IonQ (IONQ) director’s share sale part of a trading plan?

Yes. The sale of 2,757 IonQ shares was carried out under a Rule 10b5-1 trading plan. The plan was adopted on September 11, 2025, indicating that the sale timing was pre-arranged rather than a discretionary market-timing decision by the director.

How many IonQ (IONQ) shares does Gabrielle Toledano hold after these transactions?

After the reported grant and sale, Gabrielle Toledano directly holds 11,154 shares of IonQ common stock. This figure reflects her position following the 4,526-share RSU award and the open-market sale of 2,757 shares disclosed in the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 09:55 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TOLEDANO GABRIELLE B

(Last) (First) (Middle)

C/O IONQ, INC.

4505 CAMPUS DRIVE

(Street)

COLLEGE PARK MARYLAND 20740

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IonQ, Inc. [ IONQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2026		A		4,526(1)	A	$0	13,911	D
Common Stock	06/18/2026		S(2)		2,757	D	$55.01(3)	11,154	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the day before the date of the following year's Annual Meeting or (ii) June 17, 2027 subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

2. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2025.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.79 to $56.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Tyler T. Rosenbaum, Assistant Secretary, by Power of Attorney	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)